Targacept to Report Third Quarter 2013 Financial Results on November 5, 2013

  Targacept to Report Third Quarter 2013 Financial Results on November 5, 2013

Business Wire

WINSTON-SALEM, N.C. -- October 29, 2013

Targacept Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company
developing novel NNR Therapeutics™, today announced it will report financial
results for the third quarter of 2013 on Tuesday, November 5, 2013, before the
U.S. financial markets open.

Management will discuss Targacept’s financial results, provide a business and
program update, and discuss expectations for the future via conference call at
8:30 a.m. Eastern Time on Tuesday, November 5, 2013. The conference call may
be accessed by dialing 866.318.8618 for domestic participants and 617.399.5137
for international callers (reference passcode 21126805). A replay of the call
may be accessed beginning approximately two hours after its conclusion and
continuing through November 19, 2013 by dialing 888.286.8010 for domestic
callers and 617.801.6888 for international callers (reference passcode

A live audio webcast of the conference call will be accessible from the
Investor Relations page of Targacept’s website, www.targacept.com. To ensure a
timely connection to the webcast, it is recommended that users register at
least 15 minutes prior to the scheduled start time. An archived version of the
webcast will also be available for replay via the Investor Calendar section of
the Investor Relations page of Targacept’s website for at least two weeks
following the call.

About Targacept

Targacept is developing an advanced clinical pipeline of NNR Therapeutics™ to
treat patients suffering from serious nervous system and
gastrointestinal/genitourinary diseases and disorders. Many diseases arise
from abnormalities in signaling within and between the brain and other organ
systems such as the bladder and the GI tract. Targacept’s NNR Therapeutics
have the potential to normalize these signaling pathways to provide
significant medical benefit. Targacept is dedicated to building health and
restoring independence for patients. For more information, please visit

Building Health, Restoring Independence^®


Targacept, Inc.
Alan Musso, 336-480-2186
SVP, Finance and Administration and CFO
Linnden Communications
Michelle Linn, 508-362-3087
Press spacebar to pause and continue. Press esc to stop.